Health experts urge men to prioritize early prostate cancer screening. Learn about the major risk factors, lifestyle choices, ...

The agency said that although the Akeega with prednisone improved outcomes in all patients with HRR mutations, the benefits were driven by those with BRCA2 mutations.

King Charles went public with his cancer diagnosis in February 2024, but hasn't disclosed what type of the disease he has ...

The FDA approved niraparib and abiraterone acetate plus prednisone for BRCA2-mutated mCSPC, based on the AMPLITUDE trial's rPFS results. FDA approves a new treatment combining niraparib and ...

The FDA has greenlit niraparib and abiraterone acetate (AAP; Akeega) with prednisone for the treatment of adults with deleterious or suspected deleterious BRCA2 -mutated metastatic hormone-sensitive ...

The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...

The royal, who became a patron of Cancer Research UK after his own diagnosis last year, recorded a message to support the ...

King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues ...

Sir Chris Hoy’s stage-four diagnosis has put prostate cancer under the spotlight among cyclists. Cycling Weekly tackles the ...

Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of ...

Prostate cancer remains one of the most significant and preventable threats to Black men’s health, yet Black men are largely ...

Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.